Jevtana

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2010-2015
024620102015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
BACKGROUND Androgen receptor splice variant 7 (AR-V7) in circulating tumor cells (CTCs) from patients with metastatic castration… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2015
2015
We aimed to clarify the roles of the multidrug-detoxifying proteins ABCB1, ABCG2, ABCC2, and CYP3A in oral availability and brain… (More)
Is this relevant?
2015
2015
 
Is this relevant?
2013
2013
Current treatments For stage I–III patients the standard treatment includes surveillance, prostatectomy and radiotherapy. For all… (More)
  • figure 1
  • table 1
Is this relevant?
2013
2013
BACKGROUND Cabazitaxel (Jevtana) has been approved for the treatment of metastatic castration-resistant prostate cancer (mCRPC… (More)
Is this relevant?
2012
2012
OBJECTIVE This article presents current clinical evidence supporting the use of cabazitaxel (Jevtana) in men with metastatic… (More)
Is this relevant?
2012
2012
440 P&T® • August 2012 • Vol. 37 No. 8 ABSTRACT Objective: This article presents current clinical evidence supporting the use of… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
Is this relevant?